William Blair & Company’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$131K Hold
11,249
﹤0.01% 1481
2025
Q1
$83.6K Buy
+11,249
New +$83.6K ﹤0.01% 1525
2024
Q1
Sell
-14,649
Closed -$71.8K 1788
2023
Q4
$71.8K Sell
14,649
-49,015
-77% -$240K ﹤0.01% 1544
2023
Q3
$347K Sell
63,664
-13,400
-17% -$73K ﹤0.01% 1171
2023
Q2
$517K Sell
77,064
-1,800
-2% -$12.1K ﹤0.01% 1045
2023
Q1
$696K Buy
78,864
+7,618
+11% +$67.3K ﹤0.01% 935
2022
Q4
$544K Sell
71,246
-5,285
-7% -$40.4K ﹤0.01% 1016
2022
Q3
$545K Buy
76,531
+2,880
+4% +$20.5K ﹤0.01% 1011
2022
Q2
$596K Sell
73,651
-77,760
-51% -$629K ﹤0.01% 1009
2022
Q1
$2.1M Sell
151,411
-17,225
-10% -$239K 0.01% 683
2021
Q4
$4.73M Sell
168,636
-84,607
-33% -$2.37M 0.01% 485
2021
Q3
$8.61M Sell
253,243
-25,716
-9% -$874K 0.03% 350
2021
Q2
$11.4M Sell
278,959
-8,224
-3% -$336K 0.04% 303
2021
Q1
$11.6M Sell
287,183
-159,770
-36% -$6.43M 0.04% 294
2020
Q4
$26.4M Buy
446,953
+16,955
+4% +$1M 0.1% 181
2020
Q3
$20.9M Buy
429,998
+245,355
+133% +$11.9M 0.09% 186
2020
Q2
$8.93M Buy
184,643
+66,745
+57% +$3.23M 0.04% 283
2020
Q1
$3.28M Sell
117,898
-106,072
-47% -$2.95M 0.02% 418
2019
Q4
$6.7M Buy
223,970
+107,958
+93% +$3.23M 0.03% 334
2019
Q3
$3.59M Buy
+116,012
New +$3.59M 0.02% 450